Clinical trial
Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)
NCT00165035 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00165035 |
|---|---|
| Title | Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II) |
| Official title | Multi-Center, Single-Blind, Two-Arm, Randomized, Controlled, Non Inferiority Trial of the Conor CoStar Paclitaxel-Eluting Coronary Stent System vs the TAXUS DES in Patients With De Novo Lesions of the Native Coronary Arteries |
| Lead sponsor | Cordis US Corp., Industry |
| Collaborators | Conor Medsystems Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Device |
| Interventions | CoStar Paclitaxel Drug Eluting Coronary Stent System, TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent |
| Enrollment | 1,701 |
| Start date | May 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jul 1, 2011 |
| First posted | Sep 14, 2005 |
| Last update posted | Aug 4, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: